Authors:
Wuchter, C
Krappmann, D
Cai, Z
Ruppert, V
Scheidereit, C
Dorken, B
Ludwig, WD
Karawajew, L
Citation: C. Wuchter et al., In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity, LEUKEMIA, 15(6), 2001, pp. 921-928
Authors:
Heissmeyer, V
Krappmann, D
Hatada, EN
Scheidereit, C
Citation: V. Heissmeyer et al., Shared pathways of I kappa B kinase-induced SCF beta TrCP-mediated ubiquitination and degradation for the NF-kappa B precursor p105 and I kappa B alpha, MOL CELL B, 21(4), 2001, pp. 1024-1035
Authors:
Krappmann, D
Patke, A
Heissmeyer, V
Scheidereit, C
Citation: D. Krappmann et al., B-cell receptor- and phorbol ester-induced NF-kappa B and c-Jun N-terminalkinase activation in B cells requires novel protein kinase C's, MOL CELL B, 21(19), 2001, pp. 6640-6650
Authors:
Hinz, M
Loser, P
Mathas, S
Krappmann, D
Dorken, B
Scheidereit, C
Citation: M. Hinz et al., Constitutive NF-kappa B maintains high expression of a characteristic genenetwork, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells, BLOOD, 97(9), 2001, pp. 2798-2807
Authors:
Slaugenhaupt, SA
Blumenfeld, A
Gill, SP
Leyne, M
Mull, J
Cuajungco, MP
Liebert, CB
Chadwick, B
Idelson, M
Reznik, L
Robbins, CM
Makalowska, I
Brownstein, MJ
Krappmann, D
Scheidereit, C
Maayan, C
Axelrod, FB
Gusella, JF
Citation: Sa. Slaugenhaupt et al., Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia, AM J HU GEN, 68(3), 2001, pp. 598-605
Authors:
Kordes, U
Krappmann, D
Heissmeyer, V
Ludwig, WD
Scheidereit, C
Citation: U. Kordes et al., Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells, LEUKEMIA, 14(3), 2000, pp. 399-402
Authors:
Krappmann, D
Hatada, EN
Tegethoff, S
Li, J
Klippel, A
Giese, K
Baeuerle, PA
Scheidereit, C
Citation: D. Krappmann et al., The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component, J BIOL CHEM, 275(38), 2000, pp. 29779-29787
Authors:
Krappmann, D
Emmerich, F
Kordes, U
Scharschmidt, E
Dorken, B
Scheidereit, C
Citation: D. Krappmann et al., Molecular mechanisms of constitutive NF-kappa B/Rel activation in Hodgkin/Reed-Sternberg cells, ONCOGENE, 18(4), 1999, pp. 943-953
Authors:
Hinz, M
Krappmann, D
Eichten, A
Heder, A
Scheidereit, C
Strauss, M
Citation: M. Hinz et al., NF-kappa B function in growth control: Regulation of cyclin D1 expression and G(0)G(1)-to-S-Phase transition, MOL CELL B, 19(4), 1999, pp. 2690-2698
Authors:
Heissmeyer, V
Krappmann, D
Wulczyn, FG
Scheidereit, C
Citation: V. Heissmeyer et al., NF-kappa B p105 is a target of I kappa B kinases and controls signal induction of Bcl-3-p50 complexes, EMBO J, 18(17), 1999, pp. 4766-4778
Authors:
Emmerich, F
Meiser, M
Hummel, M
Demel, G
Foss, HD
Jundt, F
Mathas, S
Krappmann, D
Scheidereit, C
Stein, H
Dorken, B
Citation: F. Emmerich et al., Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells, BLOOD, 94(9), 1999, pp. 3129-3134